Warning on sleeping medicine Stilnox
The National Prescribing Service Limited (NPS) is advising consumers concerned about the possible adverse reactions associated with the sleeping medicine Stilnox (Zolpidem), to visit their doctor to assess whether they are at risk.
NPS ceo Dr Lynn Weekes says, “We recommend that consumers use non-medicine strategies to solve sleeping problems including regular exercise, relaxation and avoiding stimulants such as coffee, tea, cola and other caffeinated drinks.
“However if you are taking Zolpidem, take as little as possible for the shortest time possible.
“It is also important not to take Zolpidem on the same day as alcohol and to discuss with your doctor if you are taking any other medicines.”
NPS has issued a sleeping medicines fact sheet advising of the potential side effects of Zolpidem.
Zolpidem has been marketed in Australia since late 2000.
It is a prescription medicine that belongs to a class of sleep medicines known as imidazopyridines.
Several generic brands are available, including Dormizole, Stildem, Somidem and a sustained-release preparation known as Stilnox CR.
A related medicine is Zopiclone (Imovane, Imrest).
Zolpidem is prescribed for people who have difficulty sleeping or who have insomnia.
It is approved for short term use only (two weeks and no longer than four weeks).
See:
www.web.nps.org.au/zolpidem.
